
Xiaozhen Xie
Examiner (ID: 13269, Phone: (571)272-5569 , Office: P/1646 )
| Most Active Art Unit | 1646 |
| Art Unit(s) | 1646, 1674 |
| Total Applications | 985 |
| Issued Applications | 452 |
| Pending Applications | 103 |
| Abandoned Applications | 445 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 15254639
[patent_doc_number] => 20190376053
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-12-12
[patent_title] => COLLAGEN-BINDING AGENT COMPOSITIONS AND METHODS OF USING THE SAME
[patent_app_type] => utility
[patent_app_number] => 16/485290
[patent_app_country] => US
[patent_app_date] => 2018-02-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18178
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16485290
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/485290 | Collagen-binding agent compositions and methods of using the same | Feb 8, 2018 | Issued |
Array
(
[id] => 12837445
[patent_doc_number] => 20180170988
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-06-21
[patent_title] => BMP-7 PEPTIDES AND METHODS OF USE
[patent_app_type] => utility
[patent_app_number] => 15/891409
[patent_app_country] => US
[patent_app_date] => 2018-02-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20027
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15891409
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/891409 | BMP-7 PEPTIDES AND METHODS OF USE | Feb 7, 2018 | Abandoned |
Array
(
[id] => 18732563
[patent_doc_number] => 11801283
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-10-31
[patent_title] => Therapeutic compositions
[patent_app_type] => utility
[patent_app_number] => 16/484657
[patent_app_country] => US
[patent_app_date] => 2018-02-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 6
[patent_no_of_words] => 23306
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 97
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16484657
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/484657 | Therapeutic compositions | Feb 7, 2018 | Issued |
Array
(
[id] => 16696704
[patent_doc_number] => 10947285
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-03-16
[patent_title] => Compounds, compositions and uses thereof for improvement of bone disorders
[patent_app_type] => utility
[patent_app_number] => 15/888402
[patent_app_country] => US
[patent_app_date] => 2018-02-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 9
[patent_no_of_words] => 17202
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15888402
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/888402 | Compounds, compositions and uses thereof for improvement of bone disorders | Feb 4, 2018 | Issued |
Array
(
[id] => 15147761
[patent_doc_number] => 20190352358
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-11-21
[patent_title] => COMPOUNDS, COMPOSITIONS AND USES THEREOF FOR IMPROVEMENT OF BONE DISORDERS
[patent_app_type] => utility
[patent_app_number] => 16/482362
[patent_app_country] => US
[patent_app_date] => 2018-02-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17275
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16482362
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/482362 | COMPOUNDS, COMPOSITIONS AND USES THEREOF FOR IMPROVEMENT OF BONE DISORDERS | Feb 4, 2018 | Abandoned |
Array
(
[id] => 16367848
[patent_doc_number] => 10799583
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-10-13
[patent_title] => Treatment for bone diseases
[patent_app_type] => utility
[patent_app_number] => 15/887299
[patent_app_country] => US
[patent_app_date] => 2018-02-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 204
[patent_figures_cnt] => 12
[patent_no_of_words] => 16725
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 1178
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15887299
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/887299 | Treatment for bone diseases | Feb 1, 2018 | Issued |
Array
(
[id] => 15147819
[patent_doc_number] => 20190352387
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-11-21
[patent_title] => ANTI-SCLEROSTIN ANTIBODIES AND METHODS OF USE
[patent_app_type] => utility
[patent_app_number] => 16/480765
[patent_app_country] => US
[patent_app_date] => 2018-01-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 49652
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 50
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16480765
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/480765 | Anti-sclerostin antibodies and methods of use | Jan 28, 2018 | Issued |
Array
(
[id] => 13339805
[patent_doc_number] => 20180221442
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-08-09
[patent_title] => INHIBITION OF BONE LOSS AND INHIBITION OF ARTHRITIS BY CTHRC1
[patent_app_type] => utility
[patent_app_number] => 15/877875
[patent_app_country] => US
[patent_app_date] => 2018-01-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22698
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15877875
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/877875 | INHIBITION OF BONE LOSS AND INHIBITION OF ARTHRITIS BY CTHRC1 | Jan 22, 2018 | Abandoned |
Array
(
[id] => 16460780
[patent_doc_number] => 10844115
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-11-24
[patent_title] => Bone-targeting antibodies
[patent_app_type] => utility
[patent_app_number] => 15/875125
[patent_app_country] => US
[patent_app_date] => 2018-01-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 41
[patent_figures_cnt] => 47
[patent_no_of_words] => 21262
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15875125
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/875125 | Bone-targeting antibodies | Jan 18, 2018 | Issued |
Array
(
[id] => 13840585
[patent_doc_number] => 20190023777
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-01-24
[patent_title] => ANTIBODIES TO HUMAN GDF8
[patent_app_type] => utility
[patent_app_number] => 15/860200
[patent_app_country] => US
[patent_app_date] => 2018-01-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19048
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15860200
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/860200 | ANTIBODIES TO HUMAN GDF8 | Jan 1, 2018 | Abandoned |
Array
(
[id] => 12908926
[patent_doc_number] => 20180194817
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-07-12
[patent_title] => COMPOSITIONS AND METHODS FOR PREVENTING OR TREATING DISEASES, CONDITIONS OR PROCESSES CHARACTERIZED BY ABERRANT FIBROBLAST PROLIFERATION AND EXTRACELLULAR MATRIX DEPOSITION
[patent_app_type] => utility
[patent_app_number] => 15/855398
[patent_app_country] => US
[patent_app_date] => 2017-12-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 62255
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15855398
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/855398 | Compositions and methods for preventing or treating diseases, conditions or processes characterized by aberrant fibroblast proliferation and extracellular matrix deposition | Dec 26, 2017 | Issued |
Array
(
[id] => 12750610
[patent_doc_number] => 20180142037
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-05-24
[patent_title] => MUTANT INTERLEUKIN-2 POLYPEPTIDES
[patent_app_type] => utility
[patent_app_number] => 15/849501
[patent_app_country] => US
[patent_app_date] => 2017-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 53565
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -25
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15849501
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/849501 | Mutant interleukin-2 polypeptides | Dec 19, 2017 | Issued |
Array
(
[id] => 12239924
[patent_doc_number] => 20180072787
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-03-15
[patent_title] => 'DESIGNER OSTEOGENIC PROTEINS'
[patent_app_type] => utility
[patent_app_number] => 15/820527
[patent_app_country] => US
[patent_app_date] => 2017-11-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 24194
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15820527
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/820527 | Designer osteogenic proteins | Nov 21, 2017 | Issued |
Array
(
[id] => 13532839
[patent_doc_number] => 20180317962
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-11-08
[patent_title] => CARTILAGE REPAIR, PRESERVATION AND GROWTH BY STIMULATION OF BONE-CHONDRAL INTERFACE AND DELIVERY SYSTEM AND METHODS THEREFOR
[patent_app_type] => utility
[patent_app_number] => 15/819751
[patent_app_country] => US
[patent_app_date] => 2017-11-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10078
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15819751
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/819751 | CARTILAGE REPAIR, PRESERVATION AND GROWTH BY STIMULATION OF BONE-CHONDRAL INTERFACE AND DELIVERY SYSTEM AND METHODS THEREFOR | Nov 20, 2017 | Abandoned |
Array
(
[id] => 12624516
[patent_doc_number] => 20180100002
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-04-12
[patent_title] => COMPOSITION AND METHOD FOR DELIVERY OF BMP-2 AMPLIFIER/CO-ACTIVATOR FOR ENHANCEMENT OF OSTEOGENESIS
[patent_app_type] => utility
[patent_app_number] => 15/819444
[patent_app_country] => US
[patent_app_date] => 2017-11-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9324
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15819444
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/819444 | Composition and method for delivery of BMP-2 amplifier/co-activator for enhancement of osteogenesis | Nov 20, 2017 | Issued |
Array
(
[id] => 15145155
[patent_doc_number] => 20190351055
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-11-21
[patent_title] => Methods for Treating Bone-Related Disorders
[patent_app_type] => utility
[patent_app_number] => 16/461555
[patent_app_country] => US
[patent_app_date] => 2017-11-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11183
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16461555
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/461555 | Methods for Treating Bone-Related Disorders | Nov 15, 2017 | Abandoned |
Array
(
[id] => 14806289
[patent_doc_number] => 20190269754
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-09-05
[patent_title] => METHODS AND COMPOSITIONS FOR TREATMENT OF CARTILAGE DAMAGE AND ARTHRITIS
[patent_app_type] => utility
[patent_app_number] => 16/349435
[patent_app_country] => US
[patent_app_date] => 2017-11-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23683
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16349435
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/349435 | Methods and compositions for treatment of cartilage damage and arthritis | Nov 12, 2017 | Issued |
Array
(
[id] => 12219226
[patent_doc_number] => 20180057583
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-03-01
[patent_title] => 'ANTI-IL-25 ANTIBODIES AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 15/805584
[patent_app_country] => US
[patent_app_date] => 2017-11-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 29283
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15805584
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/805584 | Anti-IL-25 antibodies and uses thereof | Nov 6, 2017 | Issued |
Array
(
[id] => 12220746
[patent_doc_number] => 20180059107
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-03-01
[patent_title] => 'METHOD OF DETECTING OR DIAGNOSING SJOGREN\'S SYNDROME BASED ON THE PRESENCE OF AUTO-ANTIBODY AGAINST AQUAPORIN 5'
[patent_app_type] => utility
[patent_app_number] => 15/796059
[patent_app_country] => US
[patent_app_date] => 2017-10-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 4819
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15796059
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/796059 | METHOD OF DETECTING OR DIAGNOSING SJOGREN'S SYNDROME BASED ON THE PRESENCE OF AUTO-ANTIBODY AGAINST AQUAPORIN 5 | Oct 26, 2017 | Abandoned |
Array
(
[id] => 14808377
[patent_doc_number] => 20190270798
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-09-05
[patent_title] => METHODS AND COMPOSITIONS FOR MODULATON OF TRANSFORMING GROWTH FACTOR BETA-REGULATED FUNCTIONS
[patent_app_type] => utility
[patent_app_number] => 16/344311
[patent_app_country] => US
[patent_app_date] => 2017-10-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 34662
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16344311
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/344311 | Methods and compositions for modulaton of transforming growth factor beta-regulated functions | Oct 24, 2017 | Issued |